CNM Publications 2009 to Present

Selected Publications

Found 110 results
Author Title Type [ Year(Asc)]
Kitazume S, Imamaki R, Ogawa K, Komi Y, Futakawa S, Kojima S, Hashimoto Y, Marth JD, Paulson JC, Taniguchi N.  2010.  Alpha2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling.. J Biol Chem. 285(9):6515-21.
Sugahara KN, Teesalu T, Karmali PPrakash, Kotamraju VRamana, Agemy L, Greenwald DR, Ruoslahti E.  2010.  Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs.. Science. 328(5981):1031-5.
Park J-H, von Maltzahn G, Xu MJue, Fogal V, Kotamraju VRamana, Ruoslahti E, Bhatia SN, Sailor MJ.  2010.  Cooperative nanomaterial system to sensitize, target, and treat tumors.. Proc Natl Acad Sci U S A. 107(3):981-6.
Park J-H, von Maltzahn G, Ong LL, Centrone A, T Hatton A, Ruoslahti E, Bhatia SN, Sailor MJ.  2010.  Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery.. Adv Mater. 22(8):880-5.
Lee SHo, Yu S-Y, Nakayama J, Khoo K-H, Stone EL, Fukuda MN, Marth JD, Fukuda M.  2010.  Core2 O-glycan structure is essential for the cell surface expression of sucrase isomaltase and dipeptidyl peptidase-IV during intestinal cell differentiation.. J Biol Chem. 285(48):37683-92.
Gu L, Park J-H, Duong KH, Ruoslahti E, Sailor MJ.  2010.  Magnetic luminescent porous silicon microparticles for localized delivery of molecular drug payloads.. Small. 6(22):2546-52.
Fogal V, Richardson AD, Karmali PP, Scheffler IE, Smith JW, Ruoslahti E.  2010.  Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation.. Mol Cell Biol. 30(6):1303-18.
Agemy L, Sugahara KN, Kotamraju VRamana, Gujraty K, Girard OM, Kono Y, Mattrey RF, Park J-H, Sailor MJ, Jiménez AI et al..  2010.  Nanoparticle-induced vascular blockade in human prostate cancer.. Blood. 116(15):2847-56.
Takamatsu S, Antonopoulos A, Ohtsubo K, Ditto D, Chiba Y, Le DT, Morris HR, Haslam SM, Dell A, Marth JD et al..  2010.  Physiological and glycomic characterization of N-acetylglucosaminyltransferase-IVa and -IVb double deficient mice.. Glycobiology. 20(4):485-97.
Malik G, Knowles LM, Dhir, iv R, Xu S, Yang S, Ruoslahti E, Pilch J.  2010.  Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion.. Cancer Res. 70(11):4327-34.
Kolhar P, Kotamraju VRamana, Hikita ST, Clegg DO, Ruoslahti E.  2010.  Synthetic surfaces for human embryonic stem cell culture.. J Biotechnol. 146(3):143-6.
Ruoslahti E, Bhatia SN, Sailor MJ.  2010.  Targeting of drugs and nanoparticles to tumors.. J Cell Biol. 188(6):759-68.
Järvinen TAH, Ruoslahti E.  2010.  Target-seeking antifibrotic compound enhances wound healing and suppresses scar formation in mice.. Proc Natl Acad Sci U S A. 107(50):21671-6.
Park J-H, Gu L, von Maltzahn G, Ruoslahti E, Bhatia SN, Sailor MJ.  2009.  Biodegradable luminescent porous silicon nanoparticles for in vivo applications.. Nat Mater. 8(4):331-6.
Fogal V, Sugahara KN, Ruoslahti E, Christian S.  2009.  Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature.. Angiogenesis. 12(1):91-100.
Teesalu T, Sugahara KN, Kotamraju VRamana, Ruoslahti E.  2009.  C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration.. Proc Natl Acad Sci U S A. 106(38):16157-62.
Simberg D, Zhang W-M, Merkulov S, McCrae K, Park J-H, Sailor MJ, Ruoslahti E.  2009.  Contact activation of kallikrein-kinin system by superparamagnetic iron oxide nanoparticles in vitro and in vivo.. J Control Release. 140(3):301-5.
Wang H, Zhang W, Tang R, Hebbel RP, M Kowalska A, Zhang C, Marth JD, Fukuda M, Zhu C, Huo Y.  2009.  Core2 1-6-N-glucosaminyltransferase-I deficiency protects injured arteries from neointima formation in ApoE-deficient mice.. Arterioscler Thromb Vasc Biol. 29(7):1053-9.
Wang H, Tang R, Zhang W, Amirikian K, Geng Z, Geng J, Hebbel RP, Xia L, Marth JD, Fukuda M et al..  2009.  Core2 1-6-N-glucosaminyltransferase-I is crucial for the formation of atherosclerotic lesions in apolipoprotein E-deficient mice.. Arterioscler Thromb Vasc Biol. 29(2):180-7.
Simberg D, Park J-H, Karmali PP, Zhang W-M, Merkulov S, McCrae K, Bhatia SN, Sailor M, Ruoslahti E.  2009.  Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance.. Biomaterials. 30(23-24):3926-33.
Rumjantseva V, Grewal PK, Wandall HH, Josefsson EC, Sørensen ALouise, Larson G, Marth JD, Hartwig JH, Hoffmeister KM.  2009.  Dual roles for hepatic lectin receptors in the clearance of chilled platelets.. Nat Med. 15(11):1273-80.